Public Joint-Stock Company "Human Stem Cells Institute"

MISX:ISKJ 株式レポート

時価総額：₽4.3b

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Human Stem Cells Institute マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Prikhodko Viktorovich

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権1.4%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Risks To Shareholder Returns Are Elevated At These Prices For Public Joint-Stock Company "Human Stem Cells Institute" (MCX:ISKJ)

May 09
Risks To Shareholder Returns Are Elevated At These Prices For Public Joint-Stock Company "Human Stem Cells Institute" (MCX:ISKJ)

Is Human Stem Cells Institute (MCX:ISKJ) Using Too Much Debt?

Dec 25
Is Human Stem Cells Institute (MCX:ISKJ) Using Too Much Debt?

We Wouldn't Rely On Human Stem Cells Institute's (MCX:ISKJ) Statutory Earnings As A Guide

Nov 19
We Wouldn't Rely On Human Stem Cells Institute's (MCX:ISKJ) Statutory Earnings As A Guide

CEO（最高経営責任者

Prikhodko Viktorovich (63 yo)

no data

在職期間

Mr. Prikhodko Alexander Viktorovich, Ph D., served as Chairman of the Board of Public Joint-Stock Company "Human Stem Cells Institute" since July 30, 2012 until October 2020 and serves as its General Direc...